Company Announcements

Stabilisation Notice

Source: RNS
RNS Number : 3473U
Morgan Stanley & Co. Int'l plc
27 March 2023
 

27 March 2023

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Morgan Stanley

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 28 February 2023, Morgan Stanley & Co. International plc (contact: Morgan Stanley Debt Syndicate - Matteo Benedetto; telephone: +44 20 7677-3409) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014), including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

Securities

Issuer:

Morgan Stanley

Guarantor(s) (if any):

N.A.

Aggregate nominal amount:

2,000,000,000

Description:

EUR 2,000,000,000 Senior Registered Notes due 2 March 2029

ISIN:

XS2595028536

Offer price:

99.65 per cent.

 

 

Stabilisation

Stabilisation Manager(s):

MORGAN STANLEY & CO. INTERNATIONAL PLC (Coordinating Stabilisation Manager)

MUFG SECURITIES EMEA PLC

 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities referred to above have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There has not been and will not be a public offer of the securities in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAJRMTTMTTTBBJ